• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

裂谷热疫苗研发的现状

Current Status of Rift Valley Fever Vaccine Development.

作者信息

Faburay Bonto, LaBeaud Angelle Desiree, McVey D Scott, Wilson William C, Richt Juergen A

机构信息

Department of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA.

Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD), Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA.

出版信息

Vaccines (Basel). 2017 Sep 19;5(3):29. doi: 10.3390/vaccines5030029.

DOI:10.3390/vaccines5030029
PMID:28925970
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5620560/
Abstract

Rift Valley Fever (RVF) is a mosquito-borne zoonotic disease that presents a substantial threat to human and public health. It is caused by Rift Valley fever phlebovirus (RVFV), which belongs to the genus Phlebovirus and the family Phenuiviridae within the order Bunyavirales. The wide distribution of competent vectors in non-endemic areas coupled with global climate change poses a significant threat of the transboundary spread of RVFV. In the last decade, an improved understanding of the molecular biology of RVFV has facilitated significant progress in the development of novel vaccines, including DIVA (differentiating infected from vaccinated animals) vaccines. Despite these advances, there is no fully licensed vaccine for veterinary or human use available in non-endemic countries, whereas in endemic countries, there is no clear policy or practice of routine/strategic livestock vaccinations as a preventive or mitigating strategy against potential RVF disease outbreaks. The purpose of this review was to provide an update on the status of RVF vaccine development and provide perspectives on the best strategies for disease control. Herein, we argue that the routine or strategic vaccination of livestock could be the best control approach for preventing the outbreak and spread of future disease.

摘要

裂谷热(RVF)是一种由蚊子传播的人畜共患病,对人类和公共卫生构成重大威胁。它由裂谷热静脉病毒(RVFV)引起,该病毒属于布尼亚病毒目白蛉病毒属和白蛉病毒科。在非流行地区,媒介生物分布广泛,再加上全球气候变化,对RVFV的跨境传播构成了重大威胁。在过去十年中,对RVFV分子生物学的深入了解推动了新型疫苗的开发取得重大进展,包括区分感染动物和接种疫苗动物(DIVA)疫苗。尽管取得了这些进展,但在非流行国家,尚无完全许可用于兽医或人类的疫苗,而在流行国家,也没有明确的政策或做法将常规/战略牲畜疫苗接种作为预防或减轻潜在裂谷热疾病爆发的策略。本综述的目的是提供裂谷热疫苗开发现状的最新信息,并就疾病控制的最佳策略提供观点。在此,我们认为对牲畜进行常规或战略疫苗接种可能是预防未来疾病爆发和传播的最佳控制方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e577/5620560/4e54314b5099/vaccines-05-00029-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e577/5620560/4e54314b5099/vaccines-05-00029-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e577/5620560/4e54314b5099/vaccines-05-00029-g001.jpg

相似文献

1
Current Status of Rift Valley Fever Vaccine Development.裂谷热疫苗研发的现状
Vaccines (Basel). 2017 Sep 19;5(3):29. doi: 10.3390/vaccines5030029.
2
Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.裂谷热病毒MP-12疫苗通过S、M和L基因片段的部分减毒组合而完全减毒。
J Virol. 2015 Jul;89(14):7262-76. doi: 10.1128/JVI.00135-15. Epub 2015 May 6.
3
Preliminary Evaluation of a Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Providing Full Protection against Heterologous Virulent Challenge in Cattle.一种重组裂谷热病毒糖蛋白亚单位疫苗对牛异源强毒攻击提供完全保护的初步评估
Vaccines (Basel). 2021 Jul 6;9(7):748. doi: 10.3390/vaccines9070748.
4
Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.裂谷热疫苗:减毒活疫苗候选株MP-12的安全性与有效性概述
Expert Rev Vaccines. 2017 Jun;16(6):601-611. doi: 10.1080/14760584.2017.1321482. Epub 2017 May 2.
5
Candidate vaccines for human Rift Valley fever.人类裂谷热候选疫苗。
Expert Opin Biol Ther. 2019 Dec;19(12):1333-1342. doi: 10.1080/14712598.2019.1662784. Epub 2019 Sep 6.
6
A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep.一种重组裂谷热病毒糖蛋白亚单位疫苗可使绵羊完全抵御裂谷热病毒攻击。
Sci Rep. 2016 Jun 14;6:27719. doi: 10.1038/srep27719.
7
Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.通过裂谷热静脉病毒MP-12疫苗株进行种间重配的风险分析。
PLoS One. 2017 Sep 19;12(9):e0185194. doi: 10.1371/journal.pone.0185194. eCollection 2017.
8
An Overview of Rift Valley Fever Vaccine Development Strategies.裂谷热疫苗研发策略概述
Vaccines (Basel). 2022 Oct 25;10(11):1794. doi: 10.3390/vaccines10111794.
9
Immunogenicity and safety studies of an inactivated vaccine against Rift Valley fever.裂谷热灭活疫苗的免疫原性和安全性研究。
Acta Trop. 2022 Aug;232:106498. doi: 10.1016/j.actatropica.2022.106498. Epub 2022 May 2.
10
Rift Valley Fever - a Growing Threat To Humans and Animals.裂谷热——对人类和动物日益增长的威胁。
J Vet Res. 2021 Jan 26;65(1):7-14. doi: 10.2478/jvetres-2021-0009. eCollection 2021 Mar.

引用本文的文献

1
Rift Valley fever outbreak among animal handlers in Kinyogoga Village, Nakaseke District, Central Uganda: A case study.乌干达中部纳卡塞克区金约戈加村动物饲养员中裂谷热疫情:一项案例研究
PLOS Glob Public Health. 2025 Aug 25;5(8):e0003420. doi: 10.1371/journal.pgph.0003420. eCollection 2025.
2
Inter-epidemic seroprevalence of Rift Valley fever virus and associated risk factors in humans in Eastern Rwanda.卢旺达东部人群中裂谷热病毒的流行间期血清阳性率及相关危险因素
PLoS Negl Trop Dis. 2025 Aug 22;19(8):e0013405. doi: 10.1371/journal.pntd.0013405. eCollection 2025 Aug.
3
Detection and Molecular Characterization of Rift Valley Fever Virus in Apparently Healthy Cattle in Uganda.

本文引用的文献

1
An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep.表达裂谷热病毒(RVFV)Gn和Gc的1型马疱疹病毒(EHV-1)载体可在绵羊体内诱导产生中和抗体。
Virol J. 2017 Aug 14;14(1):154. doi: 10.1186/s12985-017-0811-8.
2
Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy.基于四节段裂谷热病毒的疫苗可在妊娠母羊中安全使用。
Vaccine. 2017 May 25;35(23):3123-3128. doi: 10.1016/j.vaccine.2017.04.024. Epub 2017 Apr 27.
3
Quantifying the potential pathways and locations of Rift Valley fever virus entry into the United States.
乌干达看似健康的牛群中裂谷热病毒的检测与分子特征分析
Pathogens. 2025 Jul 20;14(7):720. doi: 10.3390/pathogens14070720.
4
Has the epidemiologic conundrum of Rift Valley fever changed?裂谷热的流行病学难题有变化吗?
Trop Anim Health Prod. 2025 Jun 30;57(6):292. doi: 10.1007/s11250-025-04531-3.
5
Screening of Neutralizing Antibodies Targeting Gc Protein of RVFV.针对裂谷热病毒(RVFV)Gc蛋白的中和抗体筛选
Viruses. 2025 Apr 12;17(4):559. doi: 10.3390/v17040559.
6
A Novel BoHV-1-Vectored Subunit RVFV Vaccine Induces a Robust Humoral and Cell-Mediated Immune Response Against Rift Valley Fever in Sheep.一种新型的牛疱疹病毒1型载体亚单位裂谷热疫苗可在绵羊中诱导针对裂谷热的强烈体液免疫和细胞介导免疫反应。
Viruses. 2025 Feb 23;17(3):304. doi: 10.3390/v17030304.
7
Rift Valley Fever in Rwanda Is Urging for Enhancing Global Health Security Through Multisectoral One Health Strategy.卢旺达的裂谷热促使通过多部门一体化健康战略加强全球卫生安全。
Microorganisms. 2025 Jan 5;13(1):91. doi: 10.3390/microorganisms13010091.
8
A Lipid Nanoparticle-Formulated Self-Amplifying RNA Rift Valley Fever Vaccine Induces a Robust Humoral Immune Response in Mice.一种脂质纳米颗粒配方的自我扩增RNA裂谷热疫苗在小鼠中诱导出强烈的体液免疫反应。
Vaccines (Basel). 2024 Sep 24;12(10):1088. doi: 10.3390/vaccines12101088.
9
Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control.新发和再发传染病:全球趋势及预防和控制新策略。
Signal Transduct Target Ther. 2024 Sep 11;9(1):223. doi: 10.1038/s41392-024-01917-x.
10
The socioeconomic impacts of Rift Valley fever: A rapid review.裂谷热的社会经济影响:快速综述。
PLoS Negl Trop Dis. 2024 Aug 29;18(8):e0012347. doi: 10.1371/journal.pntd.0012347. eCollection 2024 Aug.
量化裂谷热病毒进入美国的潜在途径和位置。
Transbound Emerg Dis. 2018 Feb;65(1):85-95. doi: 10.1111/tbed.12608. Epub 2017 Feb 12.
4
Short Interfering RNA Inhibits Rift Valley Fever Virus Replication and Degradation of Protein Kinase R in Human Cells.短干扰RNA抑制裂谷热病毒在人细胞中的复制及蛋白激酶R的降解
Front Microbiol. 2016 Nov 24;7:1889. doi: 10.3389/fmicb.2016.01889. eCollection 2016.
5
Severe Human Illness Caused by Rift Valley Fever Virus in Mauritania, 2015.2015年,毛里塔尼亚出现由裂谷热病毒引起的严重人类疾病。
Open Forum Infect Dis. 2016 Sep 27;3(4):ofw200. doi: 10.1093/ofid/ofw200. eCollection 2016 Oct.
6
Notes from the Field: Rift Valley Fever Response - Kabale District, Uganda, March 2016.现场记录:裂谷热应对措施——乌干达卡巴莱区,2016 年 3 月。
MMWR Morb Mortal Wkly Rep. 2016 Nov 4;65(43):1200-1201. doi: 10.15585/mmwr.mm6543a5.
7
Widespread Rift Valley Fever Emergence in Senegal in 2013-2014.2013 - 2014年塞内加尔裂谷热疫情广泛爆发。
Open Forum Infect Dis. 2016 Jul 21;3(3):ofw149. doi: 10.1093/ofid/ofw149. eCollection 2016 Sep.
8
Association of Rift Valley fever virus infection with miscarriage in Sudanese women: a cross-sectional study.苏丹妇女中裂谷热病毒感染与流产的相关性:一项横断面研究。
Lancet Glob Health. 2016 Nov;4(11):e864-e871. doi: 10.1016/S2214-109X(16)30176-0. Epub 2016 Sep 28.
9
Safety and immunogenecity of a live attenuated Rift Valley fever vaccine (CL13T) in camels.一种骆驼用减毒活裂谷热疫苗(CL13T)的安全性和免疫原性
BMC Vet Res. 2016 Jul 26;12(1):154. doi: 10.1186/s12917-016-0775-8.
10
A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep.一种重组裂谷热病毒糖蛋白亚单位疫苗可使绵羊完全抵御裂谷热病毒攻击。
Sci Rep. 2016 Jun 14;6:27719. doi: 10.1038/srep27719.